Giacomo Bellomo

613 total citations
18 papers, 410 citations indexed

About

Giacomo Bellomo is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Giacomo Bellomo has authored 18 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Giacomo Bellomo's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Giacomo Bellomo is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Giacomo Bellomo collaborates with scholars based in Italy. Giacomo Bellomo's co-authors include Caterina Musolino, Andrea Alonci, Alessandro Allegra, Luana Calabrò, Giuseppa Penna, Antonino Cannavò, Giovanna Spatari, Sabina Russo, Vincenzo Rizzo and Vittorio Del Fabro and has published in prestigious journals such as Journal of Cellular Physiology, Biochimie and American Journal of Hematology.

In The Last Decade

Giacomo Bellomo

18 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giacomo Bellomo Italy 12 205 146 128 90 60 18 410
Amelia E. Pearsall United States 5 296 1.4× 174 1.2× 141 1.1× 97 1.1× 48 0.8× 7 506
Carolyn H. Condon United States 3 241 1.2× 83 0.6× 67 0.5× 74 0.8× 38 0.6× 6 366
Alessia Moro Italy 11 180 0.9× 206 1.4× 259 2.0× 32 0.4× 109 1.8× 20 424
Erica L. Clinkenbeard United States 15 294 1.4× 65 0.4× 52 0.4× 128 1.4× 129 2.1× 33 865
Theresa Kapral Austria 7 193 0.9× 60 0.4× 45 0.4× 99 1.1× 174 2.9× 8 405
Brigitte Spath Germany 8 134 0.7× 252 1.7× 83 0.6× 39 0.4× 12 0.2× 14 401
Kimio Morita Japan 14 119 0.6× 421 2.9× 191 1.5× 63 0.7× 80 1.3× 24 654
Sida Zhao China 11 209 1.0× 123 0.8× 106 0.8× 62 0.7× 13 0.2× 32 432
Aimalie Hardaway United States 8 187 0.9× 51 0.3× 59 0.5× 235 2.6× 27 0.5× 10 565
Anastasia Abashidze Israel 8 297 1.4× 137 0.9× 79 0.6× 103 1.1× 14 0.2× 8 560

Countries citing papers authored by Giacomo Bellomo

Since Specialization
Citations

This map shows the geographic impact of Giacomo Bellomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giacomo Bellomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giacomo Bellomo more than expected).

Fields of papers citing papers by Giacomo Bellomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giacomo Bellomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giacomo Bellomo. The network helps show where Giacomo Bellomo may publish in the future.

Co-authorship network of co-authors of Giacomo Bellomo

This figure shows the co-authorship network connecting the top 25 collaborators of Giacomo Bellomo. A scholar is included among the top collaborators of Giacomo Bellomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giacomo Bellomo. Giacomo Bellomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gangemi, Sebastiano, Alessandro Allegra, Andrea Alonci, et al.. (2012). Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflammation Research. 61(10). 1063–1067. 56 indexed citations
2.
3.
Allegra, Alessandro, Andrea Alonci, Giacomo Bellomo, et al.. (2010). Serum levels of Interleukin‐16 in a multiple myeloma patient with cutaneous involvement. International Journal of Dermatology. 49(4). 435–437. 4 indexed citations
4.
Allegra, Alessandro, Andrea Alonci, Giacomo Bellomo, et al.. (2010). Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. Leukemia & lymphoma. 52(1). 101–107. 22 indexed citations
5.
Allegra, Alessandro, Andrea Alonci, Sabina Russo, et al.. (2010). Cardiac involvement in patients with hematologic malignancies.. PubMed. 58(7). 859–74. 8 indexed citations
6.
Allegra, Alessandro, Andrea Alonci, Sabina Russo, et al.. (2010). Cardiac Involvement in Patients with Hematologic Malignancies. Journal of Investigative Medicine. 58(7). 859–874. 8 indexed citations
7.
Allegra, Alessandro, Giuseppe Coppolino, Davide Bolignano, et al.. (2009). Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. Journal of Nephrology. 22(4). 463–475. 22 indexed citations
8.
Alonci, Andrea, Alessandro Allegra, Giacomo Bellomo, et al.. (2009). Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. Medical Oncology. 27(4). 1336–1339. 2 indexed citations
9.
Alonci, Andrea, Alessandro Allegra, Giacomo Bellomo, et al.. (2008). Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. Hematological Oncology. 26(4). 235–239. 29 indexed citations
10.
Allegra, Alessandro, Giacomo Oteri, Enrico Nastro Siniscalchi, et al.. (2007). Patients with bisphosphonates‐associated osteonecrosis of the jaw have reduced circulating endothelial cells. Hematological Oncology. 25(4). 164–169. 44 indexed citations
11.
Alonci, Andrea, Alessandro Allegra, Giacomo Bellomo, et al.. (2006). Differential levels of soluble angiopoietin‐2 and Tie‐2 in patients with haematological malignancies. European Journal Of Haematology. 77(6). 480–485. 34 indexed citations
12.
Campo, Salvatore, Giuseppe M. Campo, Angela Avenoso, et al.. (2006). Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin. Biochimie. 88(12). 1933–1939. 10 indexed citations
13.
Musolino, Caterina, et al.. (2004). Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications. European Journal Of Haematology. 72(6). 416–419. 21 indexed citations
14.
Musolino, Caterina, et al.. (2002). Soluble angiogenic factors: Implications for chronic myeloproliferative disorders. American Journal of Hematology. 69(3). 159–163. 44 indexed citations
15.
Calabrò, Luana, Ester Fonsatti, Giacomo Bellomo, et al.. (2002). Differential levels of soluble endoglin (CD105) in myeloid malignancies. Journal of Cellular Physiology. 194(2). 171–175. 43 indexed citations
16.
Musolino, Caterina, et al.. (2002). [Lipid profile in hematologic neoplasms].. PubMed. 93(5). 298–301. 15 indexed citations
17.
Musolino, Caterina, Andrea Alonci, Giacomo Bellomo, et al.. (1999). Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology. 4(5). 397–402. 21 indexed citations
18.
Musolino, Caterina, Andrea Alonci, Alessandro Allegra, et al.. (1998). Increased levels of the soluble adhesion molecule E‐selectin in patients with chronic myeloproliferative disorders and thromboembolic complications. American Journal of Hematology. 57(2). 109–112. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amelia E. Pearsall Breakdown of academic impact, for papers by Carolyn H. Condon Breakdown of academic impact, for papers by Alessia Moro Breakdown of academic impact, for papers by Erica L. Clinkenbeard Breakdown of academic impact, for papers by Theresa Kapral Breakdown of academic impact, for papers by Brigitte Spath Breakdown of academic impact, for papers by Kimio Morita Breakdown of academic impact, for papers by Sida Zhao Breakdown of academic impact, for papers by Aimalie Hardaway Breakdown of academic impact, for papers by Anastasia Abashidze
Rankless by CCL
2026